Morgan Stanley’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$688K Sell
608,969
-1,744,132
-74% -$1.97M ﹤0.01% 5302
2025
Q1
$3.44M Buy
2,353,101
+1,354,505
+136% +$1.98M ﹤0.01% 4227
2024
Q4
$2.13M Sell
998,596
-722,934
-42% -$1.54M ﹤0.01% 4653
2024
Q3
$4.82M Sell
1,721,530
-435,432
-20% -$1.22M ﹤0.01% 3987
2024
Q2
$5.03M Sell
2,156,962
-75,002
-3% -$175K ﹤0.01% 3869
2024
Q1
$9.98M Sell
2,231,964
-1,103,688
-33% -$4.93M ﹤0.01% 3353
2023
Q4
$10.7M Buy
3,335,652
+1,953,934
+141% +$6.27M ﹤0.01% 3857
2023
Q3
$4.38M Buy
1,381,718
+50,281
+4% +$159K ﹤0.01% 3854
2023
Q2
$6.62M Buy
1,331,437
+349,962
+36% +$1.74M ﹤0.01% 3548
2023
Q1
$4.85M Buy
981,475
+130,996
+15% +$647K ﹤0.01% 3815
2022
Q4
$5.35M Buy
850,479
+234,460
+38% +$1.47M ﹤0.01% 3697
2022
Q3
$6.65M Sell
616,019
-521,246
-46% -$5.63M ﹤0.01% 3404
2022
Q2
$13M Sell
1,137,265
-551,176
-33% -$6.28M ﹤0.01% 2787
2022
Q1
$15.4M Buy
1,688,441
+422,386
+33% +$3.85M ﹤0.01% 2406
2021
Q4
$18.9M Buy
1,266,055
+203,029
+19% +$3.03M ﹤0.01% 2220
2021
Q3
$27.3M Sell
1,063,026
-66,452
-6% -$1.71M ﹤0.01% 1774
2021
Q2
$29.5M Buy
1,129,478
+1,035,898
+1,107% +$27M ﹤0.01% 1756
2021
Q1
$3.3M Sell
93,580
-249,202
-73% -$8.79M ﹤0.01% 3838
2020
Q4
$8.65M Buy
342,782
+142,367
+71% +$3.59M ﹤0.01% 2667
2020
Q3
$7.56M Buy
200,415
+153,345
+326% +$5.78M ﹤0.01% 2296
2020
Q2
$2.02M Sell
47,070
-259
-0.5% -$11.1K ﹤0.01% 3590
2020
Q1
$920K Sell
47,329
-32,837
-41% -$638K ﹤0.01% 4020
2019
Q4
$2.08M Buy
80,166
+48,492
+153% +$1.26M ﹤0.01% 4005
2019
Q3
$864K Buy
31,674
+21,967
+226% +$599K ﹤0.01% 4382
2019
Q2
$260K Buy
9,707
+691
+8% +$18.5K ﹤0.01% 4913
2019
Q1
$260K Sell
9,016
-27,715
-75% -$799K ﹤0.01% 4919
2018
Q4
$990K Buy
+36,731
New +$990K ﹤0.01% 4283